SC 13G/A: SANUWAVE Health, Inc.
Ticker: SNWV · Form: SC 13G/A · Filed: Oct 22, 2024 · CIK: 1417663
| Field | Detail |
|---|---|
| Company | Sanuwave Health, Inc. (SNWV) |
| Form Type | SC 13G/A |
| Filed Date | Oct 22, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by SANUWAVE Health, Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G/A filing submitted by Sanuwave Health, Inc. (ticker: SNWV) to the SEC on Oct 22, 2024.
What is the risk level of this SC 13G/A filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti).
How long is this filing?
Sanuwave Health, Inc.'s SC 13G/A filing is 4 pages with approximately 1,254 words. Estimated reading time is 5 minutes.
Where can I view the full SC 13G/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,254 words · 5 min read · ~4 pages · Grade level 8 · Accepted 2024-10-22 19:44:36
Key Financial Figures
- $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
Filing Documents
- formsc13ga.htm (SC 13G/A) — 103KB
- 0001493152-24-042119.txt ( ) — 104KB
From the Filing
SC 13G/A 1 formsc13ga.htm UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. _____5___)* Sanuwave Health, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 80303D305 (CUSIP Number) James Silverman, One Boston Place, 26 th Floor, Boston, MA 02108 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) 10/18/2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information that would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 80303D305 13G Page 2 of 6 Pages 1. NAMES OF REPORTING PERSONS Opaleye Management Inc. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 20-5648796 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 944,132 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 944,132 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 944,132 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.06% 12. TYPE OF REPORTING PERSON (see instructions) CO CUSIP No. 80303D305 13G Page 3 of 6 Pages Item 1. (a) Name of Issuer: SANUWAVE Health, Inc. (the “ Company ”). (b) Address of Issuer’s Principal Executive Offices: 11495 Valley View Rd Eden Prairie, MN 55344 Item 2. (a) Name of Person Filing: This statement is filed by the entities and persons listed below, who are collectively referred to herein as “ Reporting Persons” with respect to the shares of common stock of the Company: Opaleye Fund Opaleye, L.P. (the “ Opaleye Fund ”), a private fund formed in the state of Delaware. Investment Manager Opaleye Management Inc. (the “ Investment Manager ”), with respect to the shares of common stock held by the Opaleye Fund, a private fund to which the Investment Manager serves as investment manager. The Investment Manager also serves as a portfolio manager for a separate managed account (the “ Managed Account ”) and may be deemed to indirectly beneficially own securities owned by the Managed Account. The Investment Manager disclaims beneficial ownership of the shares held by the Managed Account. Reporting Individual Mr. James Silverman (the “ Reporting Individual” ), with respect to the shares of common stock held by the Opaleye Fund. Mr. Silverman is the President of the Investment Manager. (b) Address of the Principal Office or, if none, residence One Boston Place, 26 th Floor, Boston, MA 02108 (c) Citizenship Citizenship is set forth in Row 4 of the cover page for each Reporting Person and is incorporated herein by reference for each such Reporting Person. (d) Title of Class of Securities Common Stock, $0.001 par value per share (e) CUSIP Number 80303D305 CUSIP No. 80303D305 13G Page 4 of 6 Pages Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of